We investigated patterns of 18F-PI-2620 tau PET binding relative to individuals with Alzheimer’s disease and healthy older adults, associations between cortical 18F-PI-2620 PET uptake and cognition, and the relationship between 18F-PI-2620 PET signal in substantia nigra and motor impairment. This evidence concerns the gene MAPT and Alzheimer disease.